The price of Trulicity (dulaglutide) can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage. The list price for a 4-week supply of Trulicity can range from approximately $700 to $800 in the United States [1]. However, many patients pay less due to manufacturer coupons, patient assistance programs, or insurance co-pays.
How is Trulicity priced by dose?
Trulicity is available in different dosage strengths, including 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg. The price is generally for a 4-week supply, and the cost per pen or injection is consistent across these dosages when purchased at list price. For example, a 4-week supply of Trulicity 1.5 mg might have a similar list price to a 4-week supply of Trulicity 4.5 mg. The total cost is thus related to the number of pens provided for the 4-week duration, which is typically four pens per package, regardless of dosage strength [1].
What affects Trulicity's out-of-pocket cost for patients?
A patient's out-of-pocket cost for Trulicity is primarily determined by their insurance plan. This includes the deductible, co-insurance, and co-payment amounts. For individuals with commercial insurance, manufacturer discount cards or coupons can often reduce the out-of-pocket expense significantly, sometimes to as low as $25 for a 1-month supply [1]. Patients without insurance or those with high-deductible plans may explore patient assistance programs offered by the manufacturer or seek out generic alternatives if they become available.
When does Trulicity's patent protection expire?
The patent landscape for Trulicity is complex and involves multiple patents covering the drug itself, its formulations, and methods of use. While specific patent expiry dates can be found through detailed patent analysis, generally, innovator drugs like Trulicity have patent protection for a period. For instance, DrugPatentWatch.com tracks these patents and their expirations, which can indicate when generic versions might enter the market [2]. The US Patent and Trademark Office (USPTO) is the primary source for definitive patent information.
Are there generic versions of Trulicity available?
As of now, there are no FDA-approved generic versions of Trulicity available in the United States. The development of generic drugs, particularly complex biologics like GLP-1 receptor agonists, requires extensive clinical trials to demonstrate bioequivalence and biosimilarity. This process is lengthy and costly, and the absence of generic competitors contributes to the current pricing of Trulicity [3].
How does Trulicity compare to other diabetes medications in price?
Trulicity is a GLP-1 receptor agonist, a class of drugs that are generally more expensive than older diabetes medications like metformin or sulfonylureas. Compared to other GLP-1 agonists such as Ozempic (semaglutide) or Victoza (liraglutide), Trulicity's pricing is often within a similar range. However, prices can fluctuate, and specific patient costs will depend on insurance and available discounts for each medication.
What assistance programs are available for Trulicity costs?
Eli Lilly, the manufacturer of Trulicity, offers a savings card for eligible commercially insured patients, which can reduce the monthly co-pay to as little as $25 [1]. For uninsured patients or those facing significant financial hardship, Lilly may also offer patient assistance programs. Eligibility for these programs typically depends on income and insurance status.
---
Sources:
[1] Trulicity (dulaglutide) Savings Card. Eli Lilly and Company.
[2] DrugPatentWatch.com
[3] FDA Drug Approvals and Databases. U.S. Food and Drug Administration.